Nucleus Software Exports Limited has informed the Exchange about the Board approved the request submitted by Dr. Ritika Dusad, Executive Director for an extension of her sabbatical leave for a further period of up to one year.
NUCLEUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors of Nucleus Software Exports, at its meeting on March 25, 2026, approved an extension of sabbatical leave for Dr. Ritika Dusad, Executive Director, for a further period of up to one year. Dr. Dusad holds a Ph.D. in Physics and has over three years of experience with the company. During her sabbatical, she is pursuing a management development program and training to build business management skills, and will also explore areas of potential business interest. She will resume her executive responsibilities after the sabbatical ends. The intimation has been filed with both NSE and BSE under SEBI Listing Regulations.
This is a routine governance update with no change in leadership — Dr. Dusad remains an Executive Director and will return to her role. Short-term impact on the stock is likely neutral, though shareholders may want to monitor who is handling her executive responsibilities during the extended absence.